about
Use of mannitol inhalation challenge in assessment of cough.New and investigational treatments in cystic fibrosis.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Mannitol dry powder for inhalation: in patients with cystic fibrosis.Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.Hypertonic saline in treatment of pulmonary disease in cystic fibrosis
P2860
Q37598048-C777B8D0-CE2A-46FF-9617-0AF3134CF77CQ37849458-7A3A0C4A-4A3E-40C4-8E1C-D7466943116FQ37849777-73B86E83-6184-4753-95E2-B1CC87C0E979Q38023470-22E3DE91-31E9-46B0-95C0-057486ED975FQ38033610-894E1C4D-93B0-479B-BA75-5ECD22D11959Q45082881-EACDFE32-4EBA-4421-A8CA-B281FAEC1D4FQ58914917-A80FDC64-45B0-4CF9-BA00-B4CF853C6579
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhaled mannitol in cystic fibrosis.
@en
type
label
Inhaled mannitol in cystic fibrosis.
@en
prefLabel
Inhaled mannitol in cystic fibrosis.
@en
P2860
P1476
Inhaled mannitol in cystic fibrosis.
@en
P2093
Peter J Wills
P2860
P304
P356
10.1517/13543784.16.7.1121
P407
P577
2007-07-01T00:00:00Z